1h Free Analyst Time
The preclinical CRO market is forecasted to grow by USD 2.73 billion during 2024-2029, accelerating at a CAGR of 8.1% during the forecast period. The report on the preclinical CRO market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of chronic diseases, increase in technology and advancements in healthcare infrastructure, and growth in outsourcing of non-core functions related to preclinical CRO.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
The preclinical CRO market is segmented as below:
By End-user
- P and B companies
- Medical device companies
- Academic institutes
By Service
- Toxicology testing
- Bioanalysis and DMPK studies
- Compound management
- Others
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the preclinical CRO market covers the following areas:
- Preclinical CRO Market sizing
- Preclinical CRO Market forecast
- Preclinical CRO Market industry analysis
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Analysis
3 Market Landscape
4 Market Sizing
5 Historic Market Size
6 Qualitative Analysis
7 Five Forces Analysis
8 Market Segmentation by End-user
9 Market Segmentation by Service
10 Customer Landscape
11 Geographic Landscape
12 Drivers, Challenges, and Opportunity/Restraints
13 Competitive Landscape
14 Competitive Analysis
15 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global preclinical cro market: Altasciences, AmplifyBio, BioEmission Technology Solutions, Charles River Laboratories International Inc., Crown Bioscience, CYNBIOSE, Eurofins Scientific SE, Gempharmatech Co. Ltd., Global Center for Medical Innovation, ICON plc, Imavita S.A.S., IQVIA Holdings Inc., Kunming Biomed International Ltd., Laboratory Corp. of America Holdings, Medpace Holdings Inc., Parexel International Corp., PPD, Veeda Clinical Research Ltd., Vivotecnia, and WuXi AppTec Co. Ltd..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is increasing number of clinical trials."
According to the report, one of the major drivers for this market is the increasing prevalence of chronic diseases.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Altasciences
- AmplifyBio
- BioEmission Technology Solutions
- Charles River Laboratories International Inc.
- Crown Bioscience
- CYNBIOSE
- Eurofins Scientific SE
- Gempharmatech Co. Ltd.
- Global Center for Medical Innovation
- ICON plc
- Imavita S.A.S.
- IQVIA Holdings Inc.
- Kunming Biomed International Ltd.
- Laboratory Corp. of America Holdings
- Medpace Holdings Inc.
- Parexel International Corp.
- PPD
- Veeda Clinical Research Ltd.
- Vivotecnia
- WuXi AppTec Co. Ltd.
